Carret Asset Management’s Elevance Health ELV Stock Holding History

Carret Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-385	Closed	-$200K	–	284
2024 Q3	$200K	Sell	385 -35	-8%	-$18.7K	0.02%	273
2024 Q2	$228K	Hold	420	–	–	0.03%	247
2024 Q1	$218K	Sell	420 -50	-11%	-$24.9K	0.03%	256
2023 Q4	$222K	Hold	470	–	–	0.03%	247
2023 Q3	$205K	Hold	470	–	–	0.03%	249
2023 Q2	$209K	Hold	470	–	–	0.03%	250
2023 Q1	$216K	Hold	470	–	–	0.03%	246
2022 Q4	$241K	Buy	470 +25	+6%	+$12.7K	0.03%	242
2022 Q3	$202K	Hold	445	–	–	0.03%	257
2022 Q2	$215K	Hold	445	–	–	0.03%	262
2022 Q1	$219K	Buy	+445	New	+$203K	0.03%	277

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Carret Asset Management's ELV Position: Q4 2024 in Review

Carret Asset Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 385 shares — an estimated $200K sold.

Carret Asset Management first reported a position in ELV in Q1 2022 and held it in 11 quarters. The position peaked at $241K in Q4 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Carret Asset Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Carret Asset Management sold 385 Elevance Health shares in Q4 2024, an estimated $200K.
Carret Asset Management first reported a position in Elevance Health in Q1 2022 and held it in 11 quarters.
Carret Asset Management's Elevance Health position peaked at $241K in Q4 2022.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Carret Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.